European Foundation for the Study of Diabetes (EFSD) and Lilly EXPLORING AND APPLYING NEW STRATEGIES IN DIABETES (EXPAND) Programme
Deadline Date: 2 November 2020
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of the EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
Lilly has been a global leader in diabetes care since 1923, when Lilly introduced the world’s first commercial insulin. Today Lilly is building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing Lilly strives to make life better for people affected by diabetes and related conditions. Lilly works to deliver breakthrough outcomes through innovative solutions—from medicines and technologies to support programs and more.
Programme and Research Focus
The EFSD/Lilly EXPAND Programme aims to assess with dedicated research projects, potential strategies that could be implemented in Europe and rolled out in low-and middle income countries to favour the improvement of quality of care for all people living with diabetes. We will consider research applications in collaboration with DAC countries - the list can be viewed here:
To achieve the goals and objectives of this programme, EFSD and Lilly invite applications by issuing this “Request for Applications” (RFA). The EFSD/Lilly Programme will accept applications within any area of clinical diabetes research with emphasis on:
The overall goals are to achieve:
Mechanism of Support and Review
Research will be supported through the award of grants, each of up to 150.000 Euro. The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application. EFSD may, on advisement from the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.
Applicants who have a funding requirement larger than 150.000 Euro are also invited to apply to this programme, particularly if this relates to a clinical research project. In this case, the relevant financial requirements should be indicated and clearly justified in the budget section of the application.
Studies forming part of a larger project or matched co-funding will be considered favourably for funding but this will need to be well justified in the application (see Review Considerations).
Applications for an EFSD/Lilly Research Programme grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be normally employed at a non-profit institution in Europe or associated country (for the detailed country list, please see here).
Applications will be subject to scientific review by a specialised and independent ad hoc committee. It is expected that applications will be received, reviewed and approved for funding by January/February 2021.
Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserves the right to request revision to applications in accordance with the recommendations of the Review Committee.
Research Grant Applications
Applications for research grants will be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review and no feedback report will be provided to the applicant.
The deadline for receipt of research grant applications for funding this year is 2 November 2020.
All budgets are to be prepared in Euro. For countries in which the Euro is not yet the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under “Budget Justification”.
Applications for this programme must be submitted in the EFSD online Application System which is available via the MyEASD platform.
Members of EASD or owners of an account for the EASD Virtual Meeting or Annual Meeting registration, are asked to use the login details from their existing account (email address and password) to login to MyEASD and access the EFSD Application System.
All applications must be prepared on the official application form in the EFSD online application system and completed in strict accordance with the detailed instructions to be found there. Applications which do not comply with the instructions given in the application system will not be considered for review.
Applications must be submitted in the EFSD online application system before 23:59 CET on the deadline date 2 November 2020.
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate and independent scientific committee.
Review criteria are as follows:
Reporting Requirements and Approval of Funding
All investigators funded by this Programme are required to submit a scientific report at the end of the funding period. For those projects where funding is distributed in instalments, interim progress reports will also be required. Such reports will be subject to assessment prior to the release of any further funds.
Investigators must provide EFSD with copies of papers accepted for publication, and must acknowledge the support of the Programme in all written material by use of the phrase: "Supported by an EFSD/Lilly research grant".
Applications for a grant renewal will be accepted on a competitive basis, with the same review process as described in this Announcement. Such applications will thus be considered in the same fashion as all other new applications received for review and without any special priority.
|Application Deadline:||2 November 2020|
|Anticipated Award:||January/February 2021|
Enquiries should be directed to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3